Financing ·
Smith & Nephew plc priced a USD 700 million issuance of 5.750% Notes due 2036, with net proceeds of USD 690,928,000…
SNNSmith & Nephew PLC
Smith & Nephew plc priced a USD 700 million issuance of 5.750% Notes due 2036, with net proceeds of USD 690,928,000 after underwriting discounts. The company intends to use the majority of these funds to repurchase its outstanding 2.032% Senior Notes due 2030 via a tender offer and to cover related fees and expenses, while retaining the remainder for general corporate purposes. The transaction is scheduled to close on September 11, 2026, subject to customary conditions. Smith & Nephew operates in the medical technology industry, focusing on the repair, regeneration, and replacement of soft and hard tissue through orthopaedics, sports medicine, ENT, and advanced wound management products.